Weimu Medical develops interventional medical devices based on biomedical polymers.
Established in 2020 in Shanghai, Weimu Medical develops interventional medical devices based on biomedical polymers. Its products include embolic microspheres, varicose vein closure gel and catheters, and liquid embolic agents for oncology, medical aesthetics, and varicose vein treatments. The company launched polyvinyl alcohol embolization microspheres in March 2022 and developed varicose closure glue in April 2022. In December 2023, it raised more than CNY 100 million in Series A funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in